Detalles de la búsqueda
1.
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
Prostate;
80(5): 407-411, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31972048
2.
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.
Proc Natl Acad Sci U S A;
112(37): 11583-8, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324937
3.
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
FASEB J;
27(10): 4279-93, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23884428
4.
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.
bioRxiv;
2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38405771
5.
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.
Oncologist;
18(2): 163-73, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23340005
6.
Screening assay for blood vessel maturation inhibitors.
Biochem Biophys Res Commun;
438(2): 364-9, 2013 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23892038
7.
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications.
Nat Rev Urol;
20(5): 265-278, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36543976
8.
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.
Cancer Res Commun;
3(2): 338-346, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860652
9.
Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy.
Clin Genitourin Cancer;
20(2): 97-101, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34538582
10.
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.
J Clin Invest;
132(23)2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194476
11.
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth.
Prostate;
71(4): 333-43, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20809552
12.
HIF1 and ID1 Interplay Confers Adaptive Survival to HIF1α-Inhibition.
Front Cell Dev Biol;
9: 724059, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820369
13.
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer.
Cancer Res;
81(23): 5948-5962, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645612
14.
A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors.
Clin Cancer Res;
14(21): 6886-94, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18980983
15.
Publisher Correction: Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy.
Nat Commun;
10(1): 164, 2019 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30622254
16.
Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40.
Heliyon;
5(1): e01128, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705983
17.
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy.
Nat Commun;
9(1): 4972, 2018 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30478344
18.
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
Mol Oncol;
11(6): 655-669, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28371345
19.
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Cancer Res;
64(18): 6626-34, 2004 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15374977
20.
C/EBPß regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion.
Cancer Lett;
375(1): 152-161, 2016 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968249